Search

Author/Creator Fox, Susan M.

1. Effect of Linaclotide DR1, a Delayed‐Release Formulation of Linaclotide, in IBS‐C Patients: Analysis of Symptom Improvement Using Responder Radar Plots: 445. (October 2017)

Authors:
Chey, William D.; Bochenek, Wieslaw; Tripp, Kenneth J.; Higgins, Carolyn S.; Fox, Susan M.; Cronin, Jacquelyn A.; Chamberlin, Paul
Journal:
American journal of gastroenterology
Issue:
Volume 112(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study. Issue 5 (May 2020)

Authors:
Brenner, Darren M.; Argoff, Charles E.; Fox, Susan M.; Bochenek, Wieslaw; D'Astoli, Patricia; Blakesley, Rick E.; Reasner, David S.; O'Dea, Christopher R.; Cash, Brooks D.
Journal:
Pain
Issue:
Volume 161:Issue 5(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System. (11th September 2021)

Authors:
Chang, Lin; Lacy, Brian E.; Moshiree, Baha; Kassebaum, Amy; Abel, Jessica L.; Hanlon, Jennifer; Bartolini, Wilmin; Boinpally, Ramesh; Bochenek, Wieslaw; Fox, Susan M.; Mallick, Madhuja; Tripp, Ken; Omniewski, Nicholas; Shea, Elizabeth; Borgstein, Niels
Journal:
American journal of gastroenterology
Issue:
Volume 116:Number 9(2021)
Page Start:
1929
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation. (15th February 2021)

Authors:
Chey, William D.; Sayuk, Gregory S.; Bartolini, Wilmin; Reasner, David S.; Fox, Susan M.; Bochenek, Wieslaw; Boinpally, Ramesh; Shea, Elizabeth; Tripp, Kenneth; Borgstein, Niels
Journal:
American journal of gastroenterology
Issue:
Volume 116:Number 2(2021)
Page Start:
354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis. (3rd April 2019)

Authors:
Nee, Judy W.; Johnston, Jeffrey M.; Shea, Elizabeth P.; Walls, Courtney E.; Tripp, Kenneth; Shiff, Steven; Fox, Susan M.; Bochenek, Wieslaw; Weissman, Darren; Currie, Mark G.; Lembo, Anthony J.
Journal:
Expert review of gastroenterology & hepatology
Issue:
Volume 13:Number 4(2019)
Page Start:
397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and Tolerability of Linaclotide for the Treatment of CIC and IBS‐C: A Pooled Analysis of Phase 3‐3b Placebo‐Controlled Trials in North America: 2017 Presidential Poster Award: 477. (October 2017)

Authors:
Nee, Judy W.; Johnston, Jeffrey M.; Tripp, Kenneth J.; Van Loon, Karel; Shiff, Steven J.; Fox, Susan M.; Bochenek, Wieslaw; Weissman, Darren; Shea, Elizabeth; Lembo, Anthony J.
Journal:
American journal of gastroenterology
Issue:
Volume 112(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗